Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Lucerastat in Healthy Male Volunteers
NCT02944487Phase 1Completed
- Sponsor
- Idorsia
- Start
- Oct 2002
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lucerastat in Fabry disease (FD) (4 arms), sponsored by Idorsia. Primary endpoints: Number of participants with Adverse Events, Maximum plasma concentration up to 48 hours and 3 more. Started Oct 2002; status: completed.
02
Drugs
lucerastat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT02944487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02944487.